Skin antisepsis, oral cleansing, nasal antisepsis

Manufacturer
Sage Products, Inc. | 3M ESPE Dental Products | 3M Health Care LTD
Effective date
2012-10-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:33:23

Label at a glance#

ProductSkin antisepsis, oral cleansing, nasal antisepsis
Active ingredientchlorhexidine gluconate, POVIDONE-IODINE
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient

chlorhexidine gluconate 2% solution

Povidone-Iodine USP, 5%

OTC - PURPOSE SECTION

Purpose

Antiseptic

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE SECTION

Uses

  • helps reduce bacteria that can potentially cause skin infection
  • for preparation of skin prior to surgery

WARNINGS SECTION

Warnings

For external use only

OTC - STOP USE SECTION

Do not use

  • on patients with known allergies to chlorhexidine gluconate or any other ingredients in this product
  • for lumbar punctures or in contact with the meninges
  • on open skin wounds or as a general skin cleanser

OTC - WHEN USING SECTION

When using this product

  • keep out of eyes, ears, and mouth. May cause serious or permanent injury if chlorhexidine is permitted to enter and remain. If contact occurs, rinse with cold water right away and contact a doctor.

Do not use if you have a known sensitivity to iodine or any other ingredient in this product. Do not use in eyes. If product gets into eyes, flush immediately with water.  Do not use on infants less than 2 months old due to the risk of increased blood iodine levels.

Stop use and ask a doctor if irritation, sensitization or allergic reaction occurs. These may be signs of a serious condition.

DOSAGE & ADMINISTRATION SECTION

Directions

2% Chlorhexidine Gluconate Cloth

  • use with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.
  • do not microwave
  • product and packaging are not sterile. Follow your hospital policy for skin preparation with non-sterile products.

To open package

  • holding top of package in one hand, lift flap on backside of package with other hand
  • grasp flap at top and pull down to tear flap away and expose foam
  • hold outside of package to present foam and cloths to prep table, avoiding contact between cloths and outside of package to reduce risk of cloth contamination.

Or

  • using sterile scissors, cut off end seal of package
  • transfer contents onto prep table, avoiding contact between cloths and outside of package to reduce risk of cloth contamination
  • use first cloth to prepare the skin area indicated for a moist or dry site, making certain to keep the second cloth where it will not be contaminated. Use second cloth to prepare larger areas.
  • dry surgical sites (such as abdomen or arm): use one cloth to cleanse each 161 cm2 area (approximately 5 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard.  Allow area to air dry for one (1) minute. Do not rinse.
  • moist surgical sites (such as inguinal fold): use one cloth to cleanse each 65 cm2 area (approximately 2 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard.  Allow area to air dry for one (1) minute. Do not rinse.
  • discard each cloth after a single use
  • after package has been opened discard any unused cloths

Directions

3M Skin and Nasal Antiseptic

  • open package and remove bottle and swabs
  • unscrew cap by turning cap counter-clockwise

Skin Application:

  1. Apply to clean dry skin.
  2. Dip one swab into solution and stir vigorously for 10 seconds. Withdraw the swab slowly to avoid wiping solution off during removal.
  3. Scrub prep site for 2 minutes working from clean to dirty using both sides of the swab.
  4. Repeat steps 2 & 3 using second swab.
  5. Allow prep solution to dry. Do not blot.

Nasal Application:

  1. Use a tissue to clean the inside of both nostrils including the inside tip of nostril. Discard.
  2. Tilting the bottle slightly, dip one swab into solution and stir vigorously for 10 seconds. Withdraw the swab slowly to avoid wiping solution off during removal.
  3. Insert swab comfortably into one nostril and rotate for 15 seconds covering all surfaces. Then focus on the inside tip of nostril and rotate for an additional 15 seconds. (swab 1)
  4. Using a new swab: Repeat steps 2 & 3 with the other nostril. (swab 2)
  5. Repeat the application in both nostrils using a fresh swab each time. (swabs 3 & 4)
  6. Do not blow nose. If solution drips out of nose, it can be lightly dabbed with a tissue.

INACTIVE INGREDIENT SECTION

Inactive ingredients

2% Chlorhexidine Gluconate Cloth
aloe vera, dimethicone, fragrance, glucono-delta-lactone, glycerin, Igepal, polysorbate 20, propylene glycol, USP purified water

cloth: polyester

Inactive ingredients

3M Skin and Nasal Antiseptic
Lactic acid, lauramidopropylamine oxide, malic acid, polyquarternium-10, PPG-5-ceteth-10 phosphate, sodium hydroxide, sodium iodide, steareth-100, water, xylitol

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

2% Chlorhexidine Gluconate* Cloth
NDC 053462–705–23

2% chlorhexidine gluconate cloth
2% chlorhexidine gluconate cloth

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

3M Skin and Nasal Antiseptic
NDC 17518–060–04

3M Skin and Nasal Antiseptic NDC 17518-060-04
3M Skin and Nasal Antiseptic NDC 17518-060-04

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

3M Skin and Nasal Antiseptic
NDC 17518–060–04

NDC 17518–060–04
NDC 17518–060–04

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
846127chlorhexidine gluconate 2 % Medicated PadPSN1
252965povidone-iodine 5 % Topical SolutionPSN1
846127chlorhexidine gluconate 20 MG/ML Medicated PadSCD1
252965povidone-iodine 50 MG/ML Topical SolutionSCD1
846127chlorhexidine gluconate 2 % Medicated PadSY1
252965povidone-iodine 5 % (titratable iodine 0.5 % ) Topical SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORHEXIDINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53462-008-282020-01-31C16284748780-19d75b9d0-6748-f424-e053-dadaa90a57ce2% Chlorhexidine Gluconate Cloth and 3M Skin and Nasal Antiseptic

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17518-060-04Skin antisepsis, oral cleansing, nasal antisepsis4 mL in 1 BOTTLESOLUTION4 mL5 mg in 1mL1
53462-008-28Skin antisepsis, oral cleansing, nasal antisepsis1 in 1 KITKIT11
53462-705-23Skin antisepsis, oral cleansing, nasal antisepsis6 in 1 PACKAGECLOTH6500 mg1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17518-060SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.]1Current NDC, Legacy NDC20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip
53462-008SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.]1Legacy NDC, 3 package rows20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip
53462-705SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.]1Current NDC, Legacy NDC20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17518-060-04EA - Each17518-06087da09da-00f8-4da0-aca0-5f3802b38dbc12024-04-05
53462-705-20EA - Each53462-70507f8a3cf-9379-4359-bae1-02cecd93793c12012-07-24
53462-705-23EA - Each53462-7053d90eac6-c72f-4444-b4d0-c4ea1b1b88f012012-07-24
53462-705-26EA - Each53462-7058ee590b2-e855-4f04-8861-4ed0d0b878fc12024-04-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
chlorhexidine gluconateACTIVE INGREDIENTMOR84MUD8E1
POVIDONE-IODINEACTIVE INGREDIENT85H0HZU99M1
chlorhexidineACTIVE MOIETYR4KO0DY52L1
IODINEACTIVE MOIETY9679TC07X41
aloe vera leafINACTIVE INGREDIENTZY81Z83H0X1
dimethicone 350INACTIVE INGREDIENT2Y53S6ATLU1
gluconolactoneINACTIVE INGREDIENTWQ29KQ9POT1
glycerinINACTIVE INGREDIENTPDC6A3C0OX1
LACTIC ACIDINACTIVE INGREDIENT33X04XA5AT1
LAURAMIDOPROPYLAMINE OXIDEINACTIVE INGREDIENTI6KX160QTV1
MALIC ACIDINACTIVE INGREDIENT817L1N4CKP1
nonoxynol-9INACTIVE INGREDIENT48Q180SH9T1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999R1
polysorbate 20INACTIVE INGREDIENT7T1F30V5YH1
propylene glycolINACTIVE INGREDIENT6DC9Q167V31
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
SODIUM IODIDEINACTIVE INGREDIENTF5WR8N145C1
WATERINACTIVE INGREDIENT059QF0KO0R1
XYLITOLINACTIVE INGREDIENTVCQ006KQ1E1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53462-00853462-008-28
17518-06017518-060-04
53462-70553462-705-23

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 42 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
MALIC ACIDMALIC ACID817L1N4CKPSOLUTION / ORAL16760 mgExact identifier — unii+dosage form
2 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
8 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / TOPICAL39 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
8 equally ranked IID candidates
MALIC ACIDMALIC ACID817L1N4CKPSOLUTION / ORAL16760 mgExact identifier — unii+dosage form
2 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTSOLUTION / TOPICAL0.3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATSOLUTION / TOPICAL7.22 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUSOLUTION / TOPICAL0.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
8 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
8 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
nonoxynol-9NONOXYNOL-948Q180SH9TCLOTH / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESOLUTION / ORAL21600 mgExact identifier — unii+dosage form
2 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LACTIC ACIDLACTIC ACID33X04XA5ATSOLUTION / TOPICAL7.22 %w/wExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
4 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
nonoxynol-9NONOXYNOL-948Q180SH9TCLOTH / TOPICALNAExact identifier — unii+route+dosage form
2 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTSOLUTION / TOPICAL0.3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
8 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
8 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RCREAM / TOPICAL552 mgExact identifier — unii+route
8 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESOLUTION / ORAL21600 mgExact identifier — unii+dosage form
2 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
4 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / TOPICAL39 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCLOTH / TOPICALNAExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PEG-100 STEARATEPEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii+route
8 equally ranked IID candidates
dimethicone 350DIMETHICONE 3502Y53S6ATLUSOLUTION / TOPICAL0.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
SODIUM IODIDESODIUM IODIDEF5WR8N145CSPONGE / TOPICAL0.74 %w/wExact identifier — unii+route
4 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021669-001CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021669-00174275742026-04-25Drug product
N021669-00179350932027-10-02U-1022Drug product2011-05-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2584e616aacf4f…
2026-08-18 06:07:402026-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2531067a03dcf5…
2025-08-23 18:47 UTC2025-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-256a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-252680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-251e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-258072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-254b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2574a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-2587673890dc5c…
2021-03-12 10:30 UTC2021-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-255aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-258869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253f01610625f2…
2019-09-15 20:21 UTC2019-09N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25b00525d2431f…
2019-07-19 19:46 UTC2019-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-256a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-251c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-259b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253f0d92c62455…
2023-05-13 08:27 UTC2023-05N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25053a50430f4f…
2023-01-26 05:58 UTC2023-01N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-253a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021669-001CHLORHEXIDINE GLUCONATE2%CLOTH / TOPICALRLD, RS2005-04-25f41ea6bd6efb…

Observed Orange Book patent history#

Patent history page 1 of 5 · 184 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N021669-00174275742026-04-25Drug product84e616aacf4f…
2026-09-14 22:38:342026-08N021669-00179350932027-10-02U-1022Drug product2011-05-2484e616aacf4f…
2026-08-18 06:07:402026-07N021669-00174275742026-04-25Drug productcaaa826d4ba7…
2026-08-18 06:07:402026-07N021669-00179350932027-10-02U-1022Drug product2011-05-24caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021669-00174275742026-04-25Drug product011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021669-00179350932027-10-02U-1022Drug product2011-05-24011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00177178892025-02-27U-1022Drug product2012-05-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00174275742026-04-25Drug product31067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021669-00179350932027-10-02U-1022Drug product2011-05-2431067a03dcf5…
2025-08-23 18:47 UTC2025-08N021669-00177178892025-02-27U-1022Drug product2012-05-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021669-00174275742026-04-25Drug product6a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021669-00179350932027-10-02U-1022Drug product2011-05-246a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00177178892025-02-27U-1022Drug product2012-05-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00174275742026-04-25Drug productfd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021669-00179350932027-10-02U-1022Drug product2011-05-24fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00177178892025-02-27U-1022Drug product2012-05-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00174275742026-04-25Drug productb8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021669-00179350932027-10-02U-1022Drug product2011-05-24b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00170669162024-02-17U-73703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00177178892025-02-27U-1022Drug product2012-05-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00174275742026-04-25Drug product03ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021669-00179350932027-10-02U-1022Drug product2011-05-2403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00170669162024-02-17U-7372680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00177178892025-02-27U-1022Drug product2012-05-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00174275742026-04-25Drug product2680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021669-00179350932027-10-02U-1022Drug product2011-05-242680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00170669162024-02-17U-7375bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00177178892025-02-27U-1022Drug product2012-05-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00174275742026-04-25Drug product5bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021669-00179350932027-10-02U-1022Drug product2011-05-245bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00170669162024-02-17U-737d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00177178892025-02-27U-1022Drug product2012-05-25d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00174275742026-04-25Drug productd8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021669-00179350932027-10-02U-1022Drug product2011-05-24d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021669-00170669162024-02-17U-737d06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00177178892025-02-27U-1022Drug product2012-05-25d06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00174275742026-04-25Drug productd06236e962d9…
2024-10-29 15:01 UTC2024-10N021669-00179350932027-10-02U-1022Drug product2011-05-24d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-00170669162024-02-17U-73779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021669-00177178892025-02-27U-1022Drug product2012-05-2579d66fd596c7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CHLORHEXIDINE GLUCONATECHLORHEXIDINE GLUCONATESage Products LLCbdb6a012-37e5-4664-84a3-134bea2847442026-06-16WarningsExact identifier
ndc (package): 53462-705-23
ndc (product): 53462-705
ndc11 (package): 53462070523
3M Skin and Nasal AntisepticPOVIDONE-IODINESolventum US LLC1a94494d-7dd3-4f32-bc42-81c199fe233e2026-04-22WarningsExact identifier
ndc (package): 17518-060-04
ndc (product): 17518-060
ndc11 (package): 17518006004
d36bf0aa-9dec-3328-cab8-8fc6748dafb3d36bf0aa-9dec-3328-cab8-8fc6748dafb32012-10-22WarningsExact identifier
spl id: d36bf0aa-9dec-3328-cab8-8fc6748dafb3
spl set id: d36bf0aa-9dec-3328-cab8-8fc6748dafb3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.